title: HER-2-negative breast cancer limitations and next-generation sequencing technology promises.
authors.forename: Georgios
authors.initials: G
authors.lastname: Baltogiannis
authors.forename: Christos
authors.initials: C
authors.lastname: Katsios
authors.forename: George C
authors.initials: GC
authors.lastname: Zografos
authors.forename: Dimitrios H
authors.initials: DH
authors.lastname: Roukos
mesh_terms: D014408:Biomarkers, Tumor / Q000235:genetics*; D001943:Breast Neoplasms / Q000188:drug therapy / Q000235:genetics* / Q000401:mortality / Q000473:pathology; D018572:Disease-Free Survival; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D011379:Prognosis; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000235:genetics*; D019718:Receptors, CXCR4 / Q000235:genetics; D017422:Sequence Analysis, DNA / Q000379:methods
chemical_list: D014408:Biomarkers, Tumor; D018719:Erb-b2 Receptor Tyrosine Kinases; D019718:Receptors, CXCR4; C508053:ERBB2 protein, human